Contralateral parenchymal enhancement on dynamic contrast-enhanced MRI reproduces as a biomarker of survival in ER-positive/HER2-negative breast cancer patients

OBJECTIVES: To assess whether contralateral parenchymal enhancement reproduces as an independent biomarker for patient survival in an independent patient cohort from a different cancer institution. METHODS: This is a HIPAA-compliant IRB approved retrospective study. Patients with ER-positive/HER2-ne...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Velden, Bas H. M., Sutton, Elizabeth J., Carbonaro, Luca A., Pijnappel, Ruud M., Morris, Elizabeth A., Gilhuijs, Kenneth G. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Breast
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182741/
https://www.ncbi.nlm.nih.gov/pubmed/29736850
http://dx.doi.org/10.1007/s00330-018-5470-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182741/
https://www.ncbi.nlm.nih.gov/pubmed/29736850
http://dx.doi.org/10.1007/s00330-018-5470-7

Ejemplares similares